Clinical Practice Guidelines for the management of locally advanced ...

More documents

Recommendations

Info

10. Dunn J, et al. A review of peer support in the context of cancer. Journal of Psychosocial Oncology 2003;21(2):55-67. 11. Bloch S, Love A, Macvean M, Duchesne G, Couper J, Kissane D. Psychological adjustment of men with prostate cancer: a review of the literature. Biopsychosoc Med 2007;1:2.:2. 12. Altman DG, Schulz KF, Moher D et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001;134(8):663-694. 13. Davison BJ, Degner LF. Empowerment of men newly diagnosed with prostate cancer. Cancer Nursing 1997;20(3):187-196. 14. Lepore SJ, Helgeson VS. Psychoeducational support group enhances quality of life after prostate cancer. Cancer Research Therapy & Control 1999;Vol. 8(1-2):81-91. 15. Lepore SJ, Helgeson VS, Eton DT, Schulz R. Improving quality of life in men with prostate cancer: a randomized controlled trial of group education interventions. Health Psychology 2003;22(5):443-452. 16. Templeton H, Coates V. Evaluation of an evidence-based education package for men with prostate cancer on hormonal manipulation therapy. Patient Education & Counseling 2004;55(1):55-61. 17. Hack TF, Pickles T, Bultz BD, Degner LF, Katz A, Davison BJ. Feasibility of an audiotape intervention for patients with cancer: A multicenter, randomized, controlled pilot study. Journal of Psychosocial Oncology 1999;17(2):1-15. 18. Mishel MH, Belyea M, Germino BB et al. Helping patients with localized prostate carcinoma manage uncertainty and treatment side effects: nurse-delivered psychoeducational intervention over the telephone. Cancer 2002;94(6):1854-1866. 19. National Breast Cancer Centre, National Cancer Control Initiative. Clinical practice guidelines for the psychosocial care of adults with cancer. Canberra: NHMRC National Health and Medical Research Council, 2003 20. National Comprehensive Cancer Network. Practice Guidelines in Oncology-v.1.2002: Distress Management (Rep No. Version 1). 2002 21. Johnson JE, Lauver DR, Nail LM. Process of coping with radiation therapy. J Consult Clin Psychol 1989;57(3):358-364. 22. Johnson JE. Coping with radiation therapy: Optimism and the effect of preparatory interventions. Research in Nursing & Health 1996;19(1):-12. 23. Kim Y, Roscoe JA, Morrow GR. The effects of information and negative affect on severity of side effects from radiation therapy for prostate cancer. Supportive Care in Cancer 2002;10(5):416-421. 24. Helgeson VS, Lepore SJ, Eton DT. Moderators of the benefits of psychoeducational interventions for men with prostate cancer. Health Psychology 2006;25(3):348-354. 25. Scura KW, Budin W, Garfing E. Telephone social support and education for adaptation to prostate cancer: a pilot study. Oncology Nursing Forum 2004;2004 Mar; 31(2):335-338. 13 Psychosocial care
26. Penedo FJ, Dahn JR, Molton I et al. Cognitive-behavioral stress management improves stressmanagement skills and quality of life in men recovering from treatment of prostate carcinoma. Cancer 2004;100(1):192-200. 27. Penedo FJ, Molton I, Dahn JR et al. A randomized clinical trial of group-based cognitivebehavioral stress management in localized prostate cancer: development of stress management skills improves quality of life and benefit finding. Annals of Behavioral Medicine 2006;31(3):261-270. 28. Giesler RB, Given B, Given CW et al. Improving the quality of life of patients with prostate carcinoma: a randomized trial testing the efficacy of a nurse-driven intervention. Cancer 2005;104(4):752-762. 29. Poole G, Poon C, Achille M et al. Social support for patients with prostate cancer: The effects of support groups. Journal of Psychosocial Oncology. 2001; 19(2):1-16. 30. Weber BA, Roberts BL, Resnick M et al. The effect of dyadic intervention on self-efficacy, social support, and depression for men with prostate cancer. Psycho-Oncology 2004;13(1):47- 60. 31. Carmack Taylor CL, Demoor C, Smith MA et al. Active for Life After Cancer: a randomized trial examining a lifestyle physical activity program for prostate cancer patients. Psycho- Oncology 2006;15(10):847-862. 32. Culos-Reed S, Robinson JL. Benefits of a Physical Activity Intervention for Men With Prostate Cancer. Journal of Sport & Exercise Psychology. 2007;29(1):118-127. 33. Berglund G, Petersson LM, Eriksson KC et al. "Between Men": a psychosocial rehabilitation programme for men with prostate cancer. Acta Oncologica 2007;46(1):83-89. 34. Segal RJ, Reid RD, Courneya KS et al. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. Journal of Clinical Oncology 2003;21(9):1653-1659. 35. Galvao DA, Nosaka K, Taaffe DR et al. Resistance training and reduction of treatment side effects in prostate cancer patients. Medicine & Science in Sports & Exercise 2006;38(12):2045- 2052. 36. Windsor PM, Nicol KF, Potter J. A randomized, controlled trial of aerobic exercise for treatment-related fatigue in men receiving radical external beam radiotherapy for localized prostate carcinoma. Cancer 2004;101(3):550-557. 37. Canada AL, Neese LE, Sui D, Schover LR. Pilot intervention to enhance sexual rehabilitation for couples after treatment for localized prostate carcinoma. Cancer 2005;104(12):2689-2700. 38. Manne S, Babb J, Pinover W, Horwitz E, Ebbert J. Psychoeducational group intervention for wives of men with prostate cancer. Psycho-Oncology. 2004;13(1):37-46. 39. Campbell LC, Keefe FJ, Scipio C et al. Facilitating research participation and improving quality of life for African American prostate cancer survivors and their intimate partners. A pilot study of telephone-based coping skills training. Cancer 2007;109(2 Suppl):414-424. 40. Zabora J, Brintzenmhofeszoc K, Curbow B, Hooker C, Piantadosi S. The prevalence of psychological distress by cancer site. Psycho-Oncology 2001;(10):19-28. Clinical practice guidelines for the management of locally advanced and metastatic prostate cancer 14
Page 1: Clinical Practice Guidelines for th
Page 4 and 5: 4 Biochemical relapse .............
Page 6 and 7: FOREWORD The management of prostate
Page 8 and 9: SUMMARY OF CLINICAL PRACTICE RECOMM
Page 10 and 11: SUMMARY OF RECOMMENDATIONS Chapter
Page 12 and 13: Chapter Recommendations Grade Refs
Page 20 and 21: 1 INTRODUCTION 1.1 Natural history
Page 22 and 23: 2 PSYCHOSOCIAL CARE The diagnosis a
Page 24 and 25: 2.2 Effect of psychological and cog
Page 26 and 27: Evidence summary Level References T
Page 28 and 29: Recommendation Men with advanced pr
Page 30 and 31: An Australian cross-sectional study
Page 34 and 35: 41. Sharpley CF, Christie DRH. An a
Page 36 and 37: different treatments from different
Page 38 and 39: Evidence summary Level References I
Page 40 and 41: Evidence summary Level References F
Page 42 and 43: Despite these reservations and the
Page 44 and 45: For non-metastatic disease there we
Page 46 and 47: Evidence summary Level References T
Page 48 and 49: monotherapy for low-to-intermediate
Page 50 and 51: Evidence summary Level References M
Page 52 and 53: for surgery, suggesting that surger
Page 54 and 55: Microscopic fully resected node pos
Page 56 and 57: All three trials demonstrated impro
Page 58 and 59: Evidence summary Level References B
Page 60 and 61: of an international multicentre ran
Page 62 and 63: 45. Melton LJ, III, Alothman KI, Kh
Page 64 and 65: 76. Little DJ, Kuban DA, Levy LB, Z
Page 66 and 67: 105. Thompson IM, Tangen CM, Parade
Page 68 and 69: 4.2 Androgen deprivation therapy (e
Page 70 and 71: Evidence summary Level References F
Page 72 and 73: therapy since such studies would be
Page 74 and 75: apparent in trials comparing CAB wi
Page 76 and 77: QLQ instrument published by Cleary
Page 78 and 79: Note: Larger well-powered studies h
Page 80 and 81: Eight trials examined acute toxicit
Page 82 and 83:
half of patients experienced pain r
Page 84 and 85:
olus) in addition to radiotherapy a
Page 86 and 87:
References 1. Seidenfeld J, Samson
Page 88 and 89:
Cooperative Group. Scandinavian Jou
Page 90 and 91:
Oncology Group, TROG 96.05). Radiot
Page 92 and 93:
trial. European Journal of Cancer 1
Page 94 and 95:
6 CASTRATION-RESISTANT PROSTATE CAN
Page 96 and 97:
the median overall survival for pat
Page 98 and 99:
There are two points regarding bisp
Page 100 and 101:
with bone pain at study entry. At n
Page 102 and 103:
Recently, there have been reports o
Page 104 and 105:
of these studies 56, 58 and in the
Page 106 and 107:
Side effects (toxicity) As these ra
Page 108 and 109:
hydrocortisone respectively. Tannoc
Page 110 and 111:
5. Manikandan R, Srirangam SJ, Pear
Page 112 and 113:
33. Elomaa I, Kylmala T, Tammela T
Page 114 and 115:
60. Janknegt RA, Abbou CC, Bartolet
Page 116 and 117:
physiotherapists, occupational ther
Page 118 and 119:
7.5 Q2: Symptom control There was e
Page 120 and 121:
Informal or family caregivers deriv
Page 122 and 123:
8. Hughes SL, Weaver FM, Giobbie-Hu
Page 124 and 125:
8 COMPLEMENTARY AND ALTERNATIVE (UN
Page 126 and 127:
corresponding benefit in obstructiv
Page 128 and 129:
3. Eisenberg DM, Kessler RC, Van Ro
Page 130 and 131:
areas of the state were more likely
Page 132 and 133:
8 Miller DC, Litwin MS, Bergman J,
Page 134 and 135:
10 EMERGING THERAPIES It is impossi
Page 136 and 137:
APPENDIX 1 GUIDELINE DEVELOPMENT PR
Page 138 and 139:
study type. Studies published befor
Page 140 and 141:
Grade of recommendation Description
Page 142 and 143:
2. National Health and Research Cou
Page 144 and 145:
Dr Carole Pinnock AM Principal rese
Page 146 and 147:
Surgery Professor Villis Marshall A
Page 148 and 149:
APPENDIX 3 TNM CLASSIFICATION OF PR
Page 150 and 151:
Summary Prostate T1 T2 T3 T4 N1 M1a
Page 152 and 153:
APPENDIX 4 ABBREVIATIONS AND GLOSSA
Page 154 and 155:
Glossary Actuarial survival A metho
Page 156 and 157:
Effectiveness The extent to which a
Page 158 and 159:
Lymph nodes Small, generally pea-si
Page 160 and 161:
Each stage is divided into subgroup
Page 162 and 163:
APPENDIX 6 - ORGANISATIONS WHICH PR
Page 164 and 165:
Consultant Urologist, Royal Brisban
Page 166 and 167:
No conflict of interest to declare.
Page 168 and 169:
Index to Clinical practice guidelin
Page 170 and 171:
cardiovascular mortality 19, 54, 55
Page 172 and 173:
androgen deprivation therapy (ADT)
Page 174 and 175:
and surgery 32-34 survival 18 toxic
Page 176 and 177:
and chemotherapy 89-90 see also bon
Page 178 and 179:
spinal cord compression 62-63 see a
Page 180 and 181:
systemic 141 Tasmania Association f
show all

Clinical Practice Guidelines for the management of locally advanced ...

Create successful ePaper yourself

Delete template?

Save as template?